[1]史心怡a,王一婷b,卢 梅a.双相情感障碍患者血清Hepcidin,LncRNA MIAT 和CRE 的水平表达及与病情程度关系研究[J].现代检验医学杂志,2024,39(03):24-28+36.[doi:10.3969/j.issn.1671-7414.2024.03.004]
 SHI Xinyia,WANG Yitingb,LU Meia.Study on the Diagnostic Value of Serum NPASDP-4 and MBP Level Expression with Cognitive Dysfunction and Severity in Parkinson’s Disease Patients[J].Journal of Modern Laboratory Medicine,2024,39(03):24-28+36.[doi:10.3969/j.issn.1671-7414.2024.03.004]
点击复制

双相情感障碍患者血清Hepcidin,LncRNA MIAT 和CRE 的水平表达及与病情程度关系研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年03期
页码:
24-28+36
栏目:
论著
出版日期:
2024-05-15

文章信息/Info

Title:
Study on the Diagnostic Value of Serum NPASDP-4 and MBP Level Expression with Cognitive Dysfunction and Severity in Parkinson’s Disease Patients
文章编号:
1671-7414(2024)03-024-06
作者:
史心怡a王一婷b卢 梅a
(宝鸡市中心医院 a. 精神卫生科;b. 检验科,陕西宝鸡 721000)
Author(s):
SHI Xinyia WANG Yitingb LU Meia
(a. Department of Mental Health; b. Department of Clinical Laboratory, Baoji Central Hospital, Shaanxi Baoji 721000, China)
关键词:
双相情感障碍铁调素长链非编码RNA 心肌梗死转录本肌酐
分类号:
R749.4;R392.11
DOI:
10.3969/j.issn.1671-7414.2024.03.004
文献标志码:
A
摘要:
目的 探究双相情感障碍(bipolar disorder,BPD)患者血清铁调素(Hepcidin)、血清长链非编码RNA 心肌梗死转录本(long non-coding RNA myocardial infarction-associated transcript,LncRNA MIAT)和肌酐(creatinine,CRE)表达及与病情程度的关系。方法 选取2021 年3 月~ 2023 年3 月宝鸡市中心医院收治的150 例BPD 患者作为研究对象并纳入BPD 组,另选取健康者150 例为对照组,采用汉密尔顿抑郁量表(Hamilton depression scale,HAMD)评价抑郁,采用杨氏躁狂量表(Young mania ratings scale,YMRS)评价躁狂程度,所有研究对象均接受血清Hepcidin,LncRNA MIAT 和CRE 水平的检测。对比对照组和BPD 组血清Hepcidin,LncRNA MIAT 和CRE 水平;对比不同抑郁、躁狂程度BPD 组血清Hepcidin,LncRNAMIAT 和CRE 水平;受试者工作特征(receiver operating characteristic,ROC)曲线分析血清Hepcidin,LncRNA MIAT 和CRE对BPD的诊断价值;分析血清Hepcidin,LncRNA MIAT和CRE与BPD病情程度的关系。结果 BPD组血清Hepcidin(46.17±9.17ng/L),LncRNA MIAT(11.92±2.65)和CRE(74.02±11.89 μmol/L)水平均明显高于对照组(22.16±5.23 ng/L,4.11±0.95,57.16±8.61μmol/L),差异具有统计学意义(t=-27.856,-43.079,-14.066,均P < 0.05);随着BPD 患者抑郁、躁狂程度的增加,血清Hepcidin,LncRNA MIAT 和CRE 水平呈现升高的趋势(F=22.036,25.463,17.499;19.552,15.791,18.335,均P < 0.05);血清Hepcidin,LncRNA MIAT 和CRE 联合检测(95%CI:0.866 ~ 0.949)对BPD 诊断ROC 曲线下面积为0.914,具有较高的特异度和敏感度,显著高于血清Hepcidin(95%CI:0.693 ~ 0.816),LncRNA MIAT(95%CI:0.696 ~ 0.819)和CRE(95%CI:0.587 ~ 0.701)单独检测(AUC=0.759,0.762,0.614,均P < 0.05);血清Hepcidin,LncRNA MIAT 和CRE 与BPD 患者抑郁严重程度呈显著正相关(r=0.784,0.771,0.826,均P < 0.05);血清Hepcidin,LncRNA MIAT 和CRE 与BPD 患者躁狂严重程度呈显著正相关(r=0.806,0.793,0.831,均P < 0.05)。结论 BPD 患者血清Hepcidin,LncRNA MIAT 和CRE 水平相较正常人群更高,且与疾病严重程度呈显著正相关,联合检测对其具有较高诊断价值。
Abstract:
Objective To explore the expression of serum Hepcidin, long non-coding RNA myocardial infarction-associated transcript (LncRNA MIAT) and creatinine (CRE) in patients with bipolar disorder (BPD) and their relationship with the severity of the disease. Method In this study, 150 patients with BPD who were admitted to Baoji Central Hospital from March 2021 to March 2023 were selected as the study subjects and were included in the BPD group. Another 150 healthy subjects were selected as the control group. Hamilton Depression Scale (HAMD) was used to evaluate depression. Young mania ratings scale (YMRS) was used to evaluate the degree of mania. All subjects were tested for serum Hepcidin, LncRNA MIAT and CRE levels. The levels of serum Hepcidin, LncRNA MIAT and CRE were compared between control group and BPD group. The levels of serum Hepcidin,LncRNA MIAT and CRE in BPD groups with different depression/mania degrees were compared. Receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of serum Hepcidin, LncRNA MIAT and CRE in BPD. The relationship between serum Hepcidin, LncRNA MIAT and CRE and the severity of BPD was analyzed. Results The levels of serum Hepcidin(46.17±9.17 ng/L), LncRNA MIAT(11.92±2.65) and CRE (74.02±11.89 μmol/L)in BPD group were higher than those in control group(22.16±5.23 ng/L, 4.11±0.95, 57.16±8.61μmol/L), with significant differences (t=-27.856, -43.079, -14.066, all P<0.05). The levels of serum Hepcidin, LncRNA MIAT and CRE increased with the increase of depression/mania in BPD patients (F=22.036, 25.463, 17.499; 19.552, 15.791, 18.335, all P<0.05). The combined detection of serum Hepcidin, LncRNA MIAT and CRE (95%CI: 0.866~0.949) for BPD diagnosis had an area under the ROC curve of 0.914, with high specificity and sensitivity, which was significantly higher than that of serum Hepcidin alone (95%CI: 0.693 ~ 0.816), LncRNA MIAT (95%CI: 0.696 ~ 0.819) alone and CRE (95%CI: 0.587 ~ 0.701) detection alone (AUC=0.759, 0.762, 0.614, all P < 0.05). Serum Hepcidin, LncRNA MIAT and CRE were positively correlated with depression severity in BPD patients (r=0.784, 0.771, 0.826, all P<0.05). Serum Hepcidin, LncRNA MIAT and CRE were positively correlated with mania severity in BPD patients (r=0.806, 0.793, 0.831, all P < 0.05). Conclusion The levels of serum Hepcidin, LncRNA MIAT and CRE in BPD patients were higher than those in the normal population, and they were positively correlated with the severity of the disease. Combined detection may have a high diagnostic value.

参考文献/References:

[1] 余清平, 廖君, 梅志刚, 等. 基于SMAD4/Hepcidin通路探讨脑泰方对大鼠局灶性脑缺血后皮质铁代谢的神经元保护作用[J]. 中华中医药杂志, 2022,37(8): 4656-4660. YU Qingping, LIAO Jun, MEI Zhigang, et al. Neuroprotective effect of Naotai Formula on cortical iron metabolism in rats after focal cerebral ischemia based on SMAD4/hepcidin pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2022,37(8): 4656-4660.
[2] 孙玙, 杨水泉, 胡朝晖, 等. 血清铁调素及铁代谢指标与脑出血早期病情及预后的相关性研究[J]. 中国临床解剖学杂志, 2021, 39(3): 355-358, 362. SUN Yu, YANG Shuiquan, HU Zhaohui, et al. Research on the serum hepcidin and iron metabolism indicator in intracerebral hemorrhage and its application in assessment of early conditions and prognosis[J].Chinese Journal of Clinical Anatomy, 2021, 39(3): 355-358, 362.
[3] BILLESB?LLE C B, AZUMAYA C M, KRETSCH R C, et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms[J]. Nature, 2020,586(7831): 807-811.
[4] 左二冬, 代卫, 陆晔, 等. 放疗相关性贫血患者血清Hepcidin, EPO 表达特征[J]. 现代检验医学杂志,2020, 35(2): 43-45. ZUO Erdong, DAI Wei, LU Ye, et al. Expression features of serum hepcidin and EPO in tumor patients with radiotherapy-related anemia[J]. Journal of Modern Laboratory Medicine, 2020, 35(2): 43-45.
[5] 刘丹, 吴瑾, 周红凤, 等. LncRNA MIAT 通过miR-203 调控NPAS4 促进胃癌细胞增殖、侵袭、迁移的机制研究[J]. 现代消化及介入诊疗, 2022, 27(9):1122-1128. LIU Dan, WU Jin, ZHOU Hongfeng, et al. The mechanism of LncRNA MIAT regulates NPAS4 through miR-203 to promote the proliferation, invasion and migration of gastric cancer cells[J]. Modern Digestion & Intervention, 2022, 27(9): 1122-1128.
[6] 高珊, 杜文华, 高冠起. 2 型糖尿病患者内脏脂肪面积与糖尿病周围神经病变相关性的研究[J]. 中国糖尿病杂志, 2023, 31(5): 321-324. GAO Shan, DU Wenhua, GAO Guanqi. Correlation between visceral fat area and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus[J].Chinese Journal of Diabetes, 2023, 31(5): 321-324.
[7] 中华医学会精神医学分会双相障碍协作组. 双相障碍伴混合特征临床诊治指导建议[J]. 中华精神科杂志,2018,51(2):83-89. Bipolar Disorder Collaboration Group, Chinese Association of Psychiatry, Chinese Medical Association. Recommendations of clinical diagnosis and treatment for bipolar disorder with mixed characteristics[J].Chinese Journal of Psychiatry,2018,51(2):83-89.
[8] 史欣欣, 丁荣晶, 谢稚鹃, 等. 抑郁和躯体症状量表在冠心病患者中筛查抑郁的效度和信度[J]. 中华行为医学与脑科学杂志, 2022, 31(12): 1131-1136. SHI Xinxin, DING Rongjing, XIE Zhijuan, et al. Validity and reliability of the depression and somatic symptoms scale for screening depression among patients with coronary heart disease[J]. Chinese Journal of Behavioral Medicine and Brain Science, 2022,31(12): 1131-1136.
[9] 亢何慧娴, 莫菲萍, 刘梦慧, 等. 双相障碍躁狂发作和抑郁障碍患者心理理论研究[J]. 中国神经精神疾病杂志, 2023, 49(2): 92-96. KANG Hehuixian, MO Feiping, LIU Menghui, et al. The comparison of theory of mind in the manic phase of bipolar disorder and major depressive disorder[J].Chinese Journal of Nervous and Mental Diseases, 2023,49(2): 92-96.
[10] 王威, 薄奇静, 李峰, 等. 双相障碍患者自杀的危险因素分析[J]. 国际精神病学杂志, 2021, 48(4): 640-642, 646. WANG Wei, BO Qijing, LI Feng, et al. The analysis of risk factors of suicide in bipolar disorder patients[J].Journal of International Psychiatry, 2021, 48(4): 640-642, 646.
[11] 陈东, 周娜, 张欣, 等. 广东省双相情感障碍患者危险行为的流行病学特征及其影响因素[J]. 吉林大学学报(医学版), 2021, 47(6): 1562-1569. CHEN Dong, ZHOU Na, ZHANG Xin, et al. Epidemiological characteristics and influencing factors of risk behaviors of patients with bipolar disorder in Guangdong Province[J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1562-1569.
[12] MCINTYRE R S, PATEL M D, MASAND P S, et al. The rapid mood screener (RMS): a novel and pragmatic screener for bipolar I disorder[J].Current Medical Research and Opinion, 2021, 37(1): 135-144.
[13] SILVESTRI L, NAI A, DULJA A, et al. Hepcidin and the BMP-SMAD pathway: an unexpected liaison[J].Vitamins and Hormones, 2019, 110: 71-99.
[14] 吴迪炯, 温晓文, 刘文宾, 等. 补肾活血方对再生障碍性贫血合并铁负荷过载小鼠铁代谢的调节作用[J]. 中华中医药杂志, 2021, 36(7): 3856-3862. WU Dijiong, WEN Xiaowen, LIU Wenbin, et al. Iron metabolism regulation effect of Bushen Huoxue Formula in aplastic anemia mouse complicated with iron overload[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2021, 36(7): 3856-3862.
[15] CAMASCHELLA C, NAI A, SILVESTRI L. Iron metabolism and iron disorders revisited in the hepcidin era[J]. Haematologica, 2020, 105(2): 260-272.
[16] GINZBURG Y Z. Hepcidin-ferroportin axis in health and disease[J]. Vitamins and Hormones, 2019, 110:17-45.
[17] 都玉敏, 高莹, 安闻, 等. 颞叶癫痫幼鼠海马神经发生与Miat 及Wnt7b/β-catenin 信号通路的变化[J].儿科药学杂志, 2022, 28(10): 1-6. DU Yumin, GAO Ying, AN Wen, et al. Changes of Miat and Wnt7b/β-catenin signaling pathway in hippocampal neurogenesis of immature rats with temporal lobe epilepsy[J]. Journal of Pediatric Pharmacy, 2022, 28(10): 1-6.
[18] 何珈缘, 王清湲, 许鑫, 等. MIAT 过表达载体的构建及其对血肿瘤屏障通透性的影响[J]. 解剖科学进展, 2020, 26(1): 10-13. HE Jiayuan, WANG Qingyuan, XU Xin, et al. Construction of MIAT overexpression vector and its effect on blood tumor barrier permeability[J]. Progress of Anatomical Sciences, 2020, 26(1): 10-13.
[19] LI Dongzhe, YANG Tengyue, SHAO Chenglong, et al. LncRNA MIAT activates vascular endothelial growth factor A through RAD21 to promote nerve injury repair in acute spinal cord injury[J]. Molecular and Cellular Endocrinology, 2021, 528: 111244.
[20] 杨光, 刘雪云, 王训. 血尿素氮、肌酐及尿蛋白水平与帕金森病的相关性研究[J]. 中华神经医学杂志,2021, 20(3): 240-244. YANG Guang, LIU Xueyun, WANG Xun. Correlations of levels of blood urea nitrogen, creatinine and proteinuria with Parkinson's disease[J]. Chinese Journal of Neuromedicine, 2021, 20(3): 240-244.
[21] INKER L A, ENEANYA N D, CORESH J, et al. New creatinine - and cystatin C - based equations to estimate GFR without race[J]. New England Journal of Medicine, 2021, 385(19): 1737-1749.

相似文献/References:

[1]左二冬,代 卫,陆 晔,等.放疗相关性贫血患者血清Hepcidin,EPO 表达特征[J].现代检验医学杂志,2020,35(02):43.[doi:10.3969/j.issn.1671-7414.2020.02.013]
 ZUO Er-dong,DAI Wei,LU Ye,et al.Expression Features of Serum Hepcidin and EPO in Tumor Patients withRadiotherapy-Related Anemia[J].Journal of Modern Laboratory Medicine,2020,35(03):43.[doi:10.3969/j.issn.1671-7414.2020.02.013]
[2]王秋云,严 敏,程 珍,等.肿瘤及血液病患者血清 sTRAIL表达及与 IL-6和 Hepcidin水平的相关性研究[J].现代检验医学杂志,2021,36(01):58.[doi:10.3969/j.issn.1671-7414.2021.01.015]
 WANG Qiu-yun,YAN Min,CHENG Zhen,et al.Study of the Expression of the Serum sTRAIL, and Its Correlation with Levels of Serum IL-6 and Hepcidin in the Patients with the Tumor and Hematological Diseases[J].Journal of Modern Laboratory Medicine,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.01.015]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划 2020 SF-361:双相情感障碍患者血清因子的水平表达与病情程度关系研究。
作者简介:史心怡 (1993-),女,医学硕士,研究方向:心境障碍、睡眠障碍;E-mail:shixinyi93@21cn.com。
通讯作者:卢梅(1982-),女,医学学士,副主任医师,研究方向:儿童青少年精神障碍的诊疗,E-mail:213024279@qq.com。
更新日期/Last Update: 2024-05-15